Showing results (291-300 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|April 6, 2012
Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive diseaseNicola Hardwick, Jonathan A Ledermann, Egla Aitkens, et al.Cancer Immunology, Immunotherapy : CII|March 24, 2012
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphomaCorey M Munger, Ganapati V Hegde, Dennis D Weisenburger, et al.Cancer Immunology, Immunotherapy : CII|March 24, 2012
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapySivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Fate of intravenously administered rat lymphokine-activated killer cells labeled with different markersA A Maghazachi, L FitzgibbonCancer Immunology, Immunotherapy : CII|January 1, 1990
Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancerS P Bugis, E Lotzová, H E Savage, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-GuérinW H De Jong, E C De Boer, A P Van der Meijden, et al.Cancer Immunology, Immunotherapy : CII|February 6, 2013
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6Philippe Ulsemer, Gemma Henderson, Kawe Toutounian, et al.Cancer Immunology, Immunotherapy : CII|May 9, 2012
Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccinationSteven De Vleeschouwer, Hilko Ardon, Frank Van Calenbergh, et al.Cancer Immunology, Immunotherapy : CII|December 1, 2012
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccineMasanori Noguchi, Tetsuro Sasada, Kyogo ItohCancer Immunology, Immunotherapy : CII|February 10, 2012
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancerSandra Salvi, Vincenzo Fontana, Simona Boccardo, et al.Pageof 650